Alert on lʹAndrocur

In October 2018, France's Agence nationale de sécurité du médicament et des produits de santé alerted healthcare professionals to the risk of meningioma in connection with the use of lʹAndrocur. This drug is prescribed, in particular, as a contraceptive or as a treatment for endometriosis.